2013
DOI: 10.7196/samj.7484
|View full text |Cite
|
Sign up to set email alerts
|

South African tobacco smoking cessation clinical practice guideline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
58
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(62 citation statements)
references
References 77 publications
(80 reference statements)
3
58
0
Order By: Relevance
“…However, the safety of pharmacological treatments in pregnant women is not established and alternative strategies including an individualized plan may be necessary [112,113]. Further research is required in these preventative strategies in pregnant mothers.…”
Section: Resultsmentioning
confidence: 99%
“…However, the safety of pharmacological treatments in pregnant women is not established and alternative strategies including an individualized plan may be necessary [112,113]. Further research is required in these preventative strategies in pregnant mothers.…”
Section: Resultsmentioning
confidence: 99%
“…[1] Seventeen percent of SA adults are self-reported active smokers and an alarming 32% of pregnant women were found to be active smokers on urine cotinine testing. [2,3] Despite the publication in 2013 of the South African Tobacco Smoking Cessation Clinical Practice Guideline, [4] tobacco smoking cessation programmes in the public health sector remain scarce.…”
Section: Willingness Of Tobacco Smokers To Contribute Financially Towmentioning
confidence: 99%
“…In SA, the treatment guidelines for tobacco dependence are as follows: '(i) identifying all smokers, alerting them to the harms of smoking and benefits of quitting; (ii) assessing readiness to initiate an attempt to quit; (iii) assessing the physical and psychological dependence to nicotine and smoking; (iv) determining the best combination of counselling/support and pharmacological therapy; (v) setting a quit date and providing suitable resources and support; (vi) frequent follow-up as often as possible via text/telephone or in person; (vii) monitoring for sideeffects, relapse and ongoing cessation; and (viii) if relapse occurs, providing the necessary support and encouraging a further attempt when appropriate' . [15] These guidelines are the norm in many countries around the world. Richter and Ellerbeck [14] point out that this particular treatment guideline deviates from the treatment of most chronic health conditions (including substance abuse) in that it is an opt-in treatment.…”
Section: Defaultsmentioning
confidence: 99%